FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

126113007: Medroxyprogesterone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
12707014 Medroxyprogesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
516681000241117 médroxyprogestérone (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
730034012 Medroxyprogesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
823181000172117 médroxyprogestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
médroxyprogestérone (substance) est un(e) (attribut) Steroid hormone true Inferred relationship Some
médroxyprogestérone (substance) est un(e) (attribut) Pregnane (substance) true Inferred relationship Some
médroxyprogestérone (substance) est un(e) (attribut) Progestational hormone false Inferred relationship Some
médroxyprogestérone (substance) Has disposition (attribute) Progesterone receptor agonist (disposition) true Inferred relationship Some
médroxyprogestérone (substance) est un(e) (attribut) Progesterone false Inferred relationship Some
médroxyprogestérone (substance) est un(e) (attribut) Synthetic progestogen (substance) true Inferred relationship Some
médroxyprogestérone (substance) est un(e) (attribut) Drug allergen (substance) false Inferred relationship Some
médroxyprogestérone (substance) Has disposition (attribute) Progestational hormone (disposition) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Estradiol- and medroxyprogesterone-containing product in oral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Product containing only conjugated estrogen and medroxyprogesterone (medicinal product) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 2
Estradiol and medroxyprogesterone only product a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Product containing only medroxyprogesterone (medicinal product) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Product containing only estradiol and medroxyprogesterone in oral dose form (medicinal product form) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Medroxyprogesterone only product in oral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Conjugated estrogen and medroxyprogesterone only product in oral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 2
Medroxyprogesterone only product in parenteral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone (medicinal product) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 3
Product containing only conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 3
Conjugated estrogen- and esterified estrogen- and medroxyprogesterone-containing product in oral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 3
Conjugated estrogen and esterified estrogen and medroxyprogesterone only product a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 3
Estradiol and medroxyprogesterone only product in parenteral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Estradiol- and medroxyprogesterone-containing product in parenteral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Medroxyprogesterone acetate est un(e) (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Allergy to medroxyprogesterone Causative agent False médroxyprogestérone (substance) Inferred relationship Some
Product containing medroxyprogesterone in oral dose form (medicinal product form) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Medroxyprogesterone-containing product in parenteral dose form a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Product containing medroxyprogesterone (medicinal product) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1
Medroxyprogesterone 150mg/ml injection 1ml vial (product) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Medroxyprogesterone acetate 150mg/1mL injection (product) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Estrogens, conjugated+medroxyprogesterone acetate (product) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing conjugated estrogen and medroxyprogesterone (medicinal product) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Allergy to medroxyprogesterone Causative agent True médroxyprogestérone (substance) Inferred relationship Some 1
Medroxyprogesterone adverse reaction Causative agent True médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False médroxyprogestérone (substance) Inferred relationship Some 2
Medroxyprogesterone acetate Is modification of (attribute) True médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False médroxyprogestérone (substance) Inferred relationship Some
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False médroxyprogestérone (substance) Inferred relationship Some 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True médroxyprogestérone (substance) Inferred relationship Some 2
Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False médroxyprogestérone (substance) Inferred relationship Some 2
Product containing estradiol and medroxyprogesterone (medicinal product) a pour principe actif (attribut) True médroxyprogestérone (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start